Cytotoxic activities of new jadomycin derivatives

Jian-Ting Zheng1, Uwe Rix, Lixia Zhao

  • 1State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100080, PR. China.

The Journal of Antibiotics
|September 15, 2005
PubMed

Insights

New jadomycin derivatives show potent cytotoxic activities against various cancer cell lines. Structure-activity relationship studies reveal that side chains significantly impact biological activity, offering a scaffold for novel drug development.

Area of Science:

  • Natural Product Chemistry
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • Jadomycin B is a known cytotoxic agent.
  • Developing novel anti-cancer compounds is a critical area of research.
  • Understanding structure-activity relationships is key to drug discovery.

Purpose of the Study:

  • To evaluate the cytotoxic activities of jadomycin B and its novel derivatives.
  • To identify potent jadomycin derivatives against specific cancer cell lines.
  • To elucidate the structure-activity relationships of jadomycin derivatives.

Main Methods:

  • Cytotoxicity assays were performed against HepG2, IM-9, IM-9/Bcl-2, and H460 cancer cell lines.
  • Apoptosis induction was measured to correlate with cytotoxic potency.
  • Structure-activity relationship (SAR) analyses were conducted on the jadomycin derivatives.

Main Results:

  • Jadomycin S exhibited potent activity against HepG2, IM-9, and IM-9/Bcl-2 cells.
  • Jadomycin F demonstrated significant potency against H460 cells.
  • Potency correlated with the extent of apoptosis induced by the compounds.
  • Side chains of the oxazolone ring, derived from amino acids, significantly influenced biological activity.

Conclusions:

  • Jadomycin derivatives possess significant cytotoxic potential against diverse cancer cell lines.
  • The structural modifications, particularly side chains, are crucial for modulating anti-cancer activity.
  • Jadomycin serves as a promising scaffold for developing novel bioactive compounds with tailored therapeutic effects.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...